Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-05-01
1997-04-22
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 41, 536 172, 536 184, A61K 3170, C07H 1500
Patent
active
056229372
ABSTRACT:
This invention relates to compounds that inhibit the binding of E-selectin or P-selectin to sialyl-Lewis.sup.x or sialyl-Lewis.sup.a presented on a cell surface having the general structure: ##STR1## This invention also relates to methods of inhibiting the binding of E-selectin or P-selectin to sialyl-Lewis.sup.x or sialyl-Lewis.sup.a presented on a cell surface using said compounds and to pharmaceutically active compositions comprising compounds that inhibit the binding of E-selectin to sialyl-Lewis.sup.x and to methods of treatment of septic shock, ARDS, Crohn's disease, chronic inflammatory diseases, such as psoriasis and rheumatoid arthritis, and reperfusion injuries that occurs following heart attacks, strokes and organ transplants and to the treatment of cancer.
REFERENCES:
patent: 5211937 (1993-05-01), Brandley et al.
patent: 5212298 (1993-05-01), Rademacher et al.
patent: 5268364 (1993-12-01), Kojima et al.
patent: 5280113 (1994-01-01), Rademacher et al.
patent: 5304640 (1994-04-01), Lasky et al.
patent: 5318890 (1994-06-01), Rosen et al.
Needham et al. Proc. Natl. Acad. Sci. 1993, 90, 1359-1363.
Green et al. Biochem. Biophys. Res. Commun. 1992, 188(1), 244-251.
Springer Nature 1990, 346, 425-434.
Beck Pamela J.
Dao Huong
Dupre Brian
Kogan Timothy P.
Fonda Kathleen Kahler
Kunz Gary L.
Texas Biotechnology Corporation
LandOfFree
Compositions and methods of inhibiting the binding of E-selectin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of inhibiting the binding of E-selectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of inhibiting the binding of E-selectin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-341608